ArticleMolecular oncology2018

Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy.

Rola M Saleeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.